Administration of drugs through oral and intravenous routes is a mainstay of modern
medicine, but this approach suffers from limitations associated with off-target side effects and …

All intravenous delivered nanomedicine needs to escape from the blood vessel to exert their
therapeutic efficacy at their designated site of action. Failure to do so increases the …

Physically triggered systems hold promise for improving drug delivery by enhancing the
controllability of drug accumulation and release, lowering non-specific toxicity, and …

Cancer is one of the major leading causes of mortality in the world. The implication of
nanotherapeutics in cancer has garnered splendid attention owing to their capability to …

Breast cancer is the most common type of cancer and it is treated with surgical intervention,
radiotherapy, chemotherapy, or a combination of these regimens. Despite chemotherapy's …

Introduction Delivering sufficient therapeutics at the target site without off-target effects is a
major goal of drug delivery technology innovation. Among the established methods …

Pancreatic ductal adenocarcinomas respond poorly to chemotherapy, in part due to the
dense tumor stroma that hinders drug delivery. Ultrasound (US) in combination with …

Currently, the response to cancer treatments is highly variable, and severe side effects and
toxicity are experienced by patients receiving high doses of chemotherapy, such as those …

Acoustic nanodrops are designed to vaporize into ultrasound-responsive microbubbles,
which present certain challenges nonexistent for conventional nanoemulsions. The …

The theranostics paradigm is based on the concept of combining therapeutic and diagnostic
modalities into one platform to improve the effectiveness of treatment. Combinations of …